In today's interconnected yet fragmented pharmaceutical market, a drug's commercial success is no longer determined solely by its clinical efficacy. Its ability to demonstrate tangible value to a diverse set of global payers and health technology assessment (HTA) bodies is paramount. This discipline, known as Global Health Economics and Outcome